journal article·2017-11-03Open access

Solid lipid nanoparticles for nose to brain delivery of donepezil: formulation, optimization by Box–Behnken design, in vitro and in vivo evaluation

Mohd Yasir, Udai Vir Singh Sara, Iti Chauhan, Praveen Kumar Gaur, Alok Pratap Singh, Dinesh Puri, Ameeduzzafar

Abstract

This study was aimed at preparing and characterizing solid lipid nanoparticles (SLNs) of donepezil (DPL) for delivery to brain via nasal route. SLNs were prepared by solvent emulsification diffusion technique using glyceryl monostearate (GMS) as lipid and blend of tween 80 and poloxamer 188 (1:1) as surfactant. Box–Behnken design was applied for optimization by using drug to lipid ratio, surfactant concentration and stirring time as dependent variables and their effect were observed on particles size, entrapment efficiency and drug loading. Optimized formulation was evaluated for particle size, zeta potential, entrapment efficiency, drug loading, morphological analysis, crystallinity, in vitro drug release, in vivo (biodistribution, pharmacokinetic and Gama scintigraphy) studies. For optimized formulation (OD3), value of particle size, zeta potential, percent in vitro release, entrapment efficiency and drug loading was found to be 121.0 nm, –24.1 mV, 89.35%, 67.95% and 12.15%, respectively. Pharmacokinetic and biodistribution studies were performed on albino Wistar rats and value of AUC0–∞ in brain for DPL-SLNs i.n. was found to be nearly 2.61 times higher than that of DPL-Sol i.v., whereas 2.26 times superior than DPL-Sol administered intranasally. The scintigraphy images were taken in rabbit and result revealed the localization of drug in brain.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Advancements in Transdermal Drug Delivery · Lipid Membrane Structure and Behavior

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacy, Uttarakhand Technical University, Dehradun, India;

I.T.S. College of Pharmacy, Ghaziabad, India;

Dr. M. C. Saxena College of Pharmacy, Lucknow, India;

College of Pharmacy, Aljouf University, Sakaka, Saudi Arabia

Funding

I.T.S. College of Pharmacy

References (40)

Show source-provided references
1. Mishra A · J Pharm Pharm Sci · 2003 · 6 · 252
2. 10.1016/j.ejpb.2014.05.00410.1016/j.ejpb.2014.05.004 ↗
3. 10.1016/S1359-6446(02)02529-110.1016/S1359-6446(02)02529-1 ↗
4. 10.1016/S0169-409X(97)00065-310.1016/S0169-409X(97)00065-3 ↗
5. 10.3109/1061186090338693810.3109/10611860903386938 ↗
6. 10.1016/j.addr.2007.04.01110.1016/j.addr.2007.04.011 ↗
7. 10.1016/0168-3659(94)90047-710.1016/0168-3659(94)90047-7 ↗
8. 10.1016/j.jconrel.2007.12.01810.1016/j.jconrel.2007.12.018 ↗
9. 10.1016/j.jcis.2009.03.01210.1016/j.jcis.2009.03.012 ↗
10. 10.1016/j.dit.2013.06.01110.1016/j.dit.2013.06.011 ↗
11. Areosa SA · Cochrane Database Syst Rev · 2003 · 20 · 154
12. 10.1002/rcm.271810.1002/rcm.2718 ↗
13. 10.1016/j.jns.2005.08.02110.1016/j.jns.2005.08.021 ↗
14. 10.1211/jpp.61.05.001710.1211/jpp.61.05.0017 ↗
15. 10.1016/j.ajps.2015.06.00110.1016/j.ajps.2015.06.001 ↗
16. 10.1046/j.1365-2125.1998.0460s1019.x10.1046/j.1365-2125.1998.0460s1019.x ↗
17. 10.1016/j.ijpharm.2007.05.06110.1016/j.ijpharm.2007.05.061 ↗
18. 10.1007/s10856-012-4702-710.1007/s10856-012-4702-7 ↗
19. 10.1016/S0378-5173(03)00135-210.1016/S0378-5173(03)00135-2 ↗
20. 10.3109/02652048.2011.58086110.3109/02652048.2011.580861 ↗
21. 10.1016/j.jconrel.2003.11.01210.1016/j.jconrel.2003.11.012 ↗
22. 10.3109/0898210090344306510.3109/08982100903443065 ↗
23. 10.1016/j.jpba.2013.06.01610.1016/j.jpba.2013.06.016 ↗
24. 10.1016/j.ifset.2014.06.01210.1016/j.ifset.2014.06.012 ↗
25. 10.1248/cpb.49.144410.1248/cpb.49.1444 ↗
26. 10.1016/j.apsb.2014.10.00510.1016/j.apsb.2014.10.005 ↗
27. 10.1016/S0731-7085(01)00499-X10.1016/S0731-7085(01)00499-X ↗
28. 10.1016/j.ijpharm.2013.04.08410.1016/j.ijpharm.2013.04.084 ↗
29. 10.1016/j.ejpb.2008.07.00510.1016/j.ejpb.2008.07.005 ↗
30. 10.1007/s13346-012-0110-210.1007/s13346-012-0110-2 ↗
31. 10.1208/ps06011210.1208/ps060112 ↗
32. 10.1016/j.addr.2007.04.01310.1016/j.addr.2007.04.013 ↗
33. 10.1155/2017/212073410.1155/2017/2120734 ↗
34. 10.1016/j.ijpharm.2014.08.00310.1016/j.ijpharm.2014.08.003 ↗
35. 10.1007/s11095-009-0041-x10.1007/s11095-009-0041-x ↗
36. 10.1016/S0168-3659(02)00363-210.1016/S0168-3659(02)00363-2 ↗
37. 10.1016/S0169-409X(00)00122-810.1016/S0169-409X(00)00122-8 ↗
38. 10.1186/1471-2202-6-6110.1186/1471-2202-6-61 ↗
39. 10.1021/mp800032f10.1021/mp800032f ↗
40. 10.1016/j.tube.2005.08.00910.1016/j.tube.2005.08.009 ↗